Search

everythinglearnresearchcommunity

for

Search:↓

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Too much epidermal growth factor can cause hair loss.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

Sex and sex hormones can affect brain inflammation in Parkinson's disease, with male mice being more affected and female mice showing a protective effect.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

Exosomes could be a promising way to help repair skin and treat skin disorders.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Melanocytes are important for normal body functions and have potential uses in regenerative medicine and disease treatment.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Some children may develop hair loss after having COVID-19.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

Advancements in tissue engineering show promise for hair follicle regeneration to treat hair loss.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Genetics play a role in acne, but how exactly they contribute is not fully understood.

The hepatitis B vaccine did not cause hair loss in the tested mice.

Artificial skin is improving wound healing and shows potential for treating different types of wounds.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Follicular Cell Implantation might become a new treatment for hair loss and could lead to advances in organ regeneration.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

Manipulating cell cleanup processes could help treat hair loss.

Pregnancy can cause skin changes and affect existing skin conditions, with limited treatment options due to the need for fetal safety.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.